betafuse vet 1 mg/g + 5 mg/g geeli
norbrook laboratories (ireland) limited - betamethasone valerate, fusidic acid - geeli - 1 mg/g + 5 mg/g - beetametasoni ja antibiootit
fesoterodine stada 8 mg depottabletti
stada arzneimittel ag - fesoterodine fumarate - depottabletti - 8 mg - fesoterodiini
fesoterodine stada 4 mg depottabletti
stada arzneimittel ag - fesoterodine fumarate - depottabletti - 4 mg - fesoterodiini
tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiset aineet - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.
memantine accord
accord healthcare s.l.u. - memantiinihydrokloridia - alzheimerin tauti - muut dementia-lääkkeet - alzheimerin taudin keskivaikean tai vaikean potilaan hoito.
flunixin 50 mg/ml injektioneste, liuos
norbrook laboratories (ireland) limited - flunixin meglumine - injektioneste, liuos - 50 mg/ml - fluniksiini
vetofol vet 10 mg/ml injektioneste, emulsio
norbrook laboratories (ireland) limited - propofol - injektioneste, emulsio - 10 mg/ml - propofoli
flunixin vet 25 mg/g rakeet
norbrook laboratories (ireland) limited - flunixini megluminas - rakeet - 25 mg/g - fluniksiini
noroseal 2.6 g intramammaarisuspensio
norbrook laboratories (ireland) limited - bismuth subnitrate - intramammaarisuspensio - 2.6 g - muut vetimien ja utareiden hoitoon tarkoitetut valmisteet
cordarone 200 mg tabletti
paranova oy - amiodaroni hydrochloridum - tabletti - 200 mg - amiodaroni